Skip to main content
. 2014 Feb 12;4(4):445–459. doi: 10.7150/thno.7653

Figure 6.

Figure 6

RuBpy-doped NPs showed increased lung oxidation in vivo. (A) Increased MPO activity in lung but not in the kidney and liver in RuBpy-doped NPs treated mice (n=5). (B) Increased levels of lipid peroxidation were observed in the lung, but not in the kidney and liver tissues of RuBpy-doped NPs treated mice as assessed by the thiobarbituric acid-reactive substance assay. The data are presented as means±SEM and are representative of three experiments (one-way ANOVA (Tukey's post hoc); * p < 0.05). RLU, relative luciferase units.